Increasing Number of Burn Injuries, Trauma and Accidents to Boost the Amniotic Membrane Market Growth

Amniotic Membrane Market, by Product Type (Amniotic Membranes {Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes}, and Amniotic Suspensions), by Application (Wound Care, Orthopedics, Ophthalmology, and Others), by End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Research and Academic Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

The global Amniotic Market is estimated to be valued at US$ XX million in XXX and is expected to exhibit a CAGR of XX% over the forecast period, as highlighted in a new report published by Coherent Market Insights. Amniotic membrane is the deepest layer of the placenta (a tube that connects the mother and child) and comprise of a thick layer membrane and stromal matrix which is avascular. Amniotic membrane grafting has been utilized as a implant or as a covering in various medical branches.

The global Amniotic Membrane Market is estimated to be valued at US$ 3,201.1 Mn in 2021, and is expected to exhibit a CAGR of 12.8% over the forecast period (2021-2028).

Key players involved in the global amniotic membrane market are Human Regenerative Technologies, Next Biosciences,Smith & Nephew, Integra LifeSciences, Applied Biologics, Skye Biologics Inc., NuVision Biotherapies, Wright Medical, Amniox Medical, Inc, TissueTech, Katena Products, Inc., Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, MiMedx, LifeCell International, LLC, Surgenex, and Ventris Medical.

Market Key Drivers:

Increasing number of burn injuries, trauma and accidents are expected to augment the growth of the global amniotic market. For instance, as per LMICs, around 9 million people get affected from burn injuries and around 120,000–180,000 deaths yearly across the globe.

The rising innovation in products and the quick launches of the product is projected to boost the growth of global amniotic market. For example, in August 2021, Vivex Biologics, Inc., a regenerative pharmaceutical company, introduced CYGNUS Matrix Disks, from the CYGNUS family of amniotic tissue implantation.

Covid-19 Impact Analysis:

The Covid-19 outbreak had adversely affected the growth of global amniotic market owing to the reduction in the distribution of medical commodities, postponement in ophthalmological operation and threat of positive COVID-19 cases linked with amniotic membrane.

Key Takeaways:

The global amniotic market is expected to exhibit a CAGR of XX % during the forecast period due rising R&D, quick product launches and approvals. For instance, in July 2020, Merakris, a pharmaceutical company developing wound-healing commodities for dermis and optics, introduced a new skin-implant substitute to aid guard and recover injuries.

Among region North America, Asia Pacific and Europe are anticipated to witness robust growth in the global amniotic market due to rising investments, increasing new innovations, rising geriatric population, increasing wound injury, rising approvals and quick launches. For instance, in March 2021, TissueTech was approved by USFDA to continue with a Phase II study utilizing morselized CAM and CUC Investigational New Drug TTBT01.


Comments

Popular posts from this blog

Refinery Catalysts are Important Components of a Petroleum Refinery

Wearable Injector are Devices Which Adhere to the Body and Help in Administering Drug to the Patient

Global Flocculant And Coagulant Market Is Estimated To Witness High Growth Owing To Increasing Demand For Water Treatment Applications